Pioglitazone Modulates the Proliferation and Apoptosis of Vascular Smooth Muscle Cells Via Peroxisome Proliferators-activated Receptor-gamma

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2014 Oct 11

PMID 25302079

Citations 9

Authors

Jing Wan

Zhichao Xiao

Shengping Chao

Shixi Xiong

Xuedong Gan

Xuguang Qiu

Chang Xu

Yexin Ma

Xin Tu

Affiliations

Soon will be listed here.

Abstract

Background: PPARγ is a member of the nuclear hormone receptor superfamily. It has been considered as a mediator regulating metabolism, anti-inflammation, and pro-proliferation in the Vascular Smooth Muscle Cells (VSMCs). Thiazolidinediones (TZDs), synthetic ligands of PPARγ, have anti-proliferative and pro-apoptotic effects on VSMCs, which prevent the formation and progression of atherosclerosis and restenosis following percutaneous coronary intervention (PCI). However, the underlying mechanism remains elusive. This present study therefore aimed to investigate the signaling pathway by which pioglitazone, one of TZDs, inhibits proliferation and induces apoptosis of VSMCs.

Methods: The effects of pioglitazone on VSMC proliferation and apoptosis were studied. Cell proliferation was determined using BrdU incorporation assay. Cell apoptosis was monitored with Hoechst and Annexin V staining. The expression of caspases and cyclins was determined using real-time PCR and Western blot.

Results: Pioglitazone treatment and PPARγ overexpression inhibited proliferation and induced apoptosis of VSMCs, whereas blocking by antagonist or silencing by siRNA of PPARγ significantly attenuated pioglitazone's effect. Furthermore, pioglitazone treatment or PPARγ overexpression increased caspase 3 and caspase 9 expression, and decreased the expression of cyclin B1 and cyclin D1 in VSMCs.

Conclusions: Pioglitazone inhibits VSMCs proliferation and promotes apoptosis of VSMCs through a PPARγ signaling pathway. Up-regulation of caspase 3 and down-regulation of cyclins mediates pioglitazone's anti-proliferative and pro-apoptotic effects. Our results imply that pioglitazone prevents the VSMCs proliferation via modulation of caspase and cyclin signaling pathways in a PPARγ-dependent manner.

Citing Articles

Traditional chinese medicine to prevent and treat diabetic erectile dysfunction.

Feng Y, Shi T, Fu Y, Lv B Front Pharmacol. 2022; 13:956173.

PMID: 36210810 PMC: 9532934. DOI: 10.3389/fphar.2022.956173.

Morphine enhances LPS-induced macrophage apoptosis through a PPARγ-dependent mechanism.

Lin M, Deng K, Li Y, Wan J Exp Ther Med. 2021; 22(1):714.

PMID: 34007323 PMC: 8120503. DOI: 10.3892/etm.2021.10146.

PPARγ enhances ILC2 function during allergic airway inflammation via transcription regulation of ST2.

Xiao Q, He J, Lei A, Xu H, Zhang L, Zhou P Mucosal Immunol. 2020; 14(2):468-478.

PMID: 32811992 DOI: 10.1038/s41385-020-00339-6.

PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma.

Zhao M, Li X, Zhang Y, Zhu H, Han Z, Kang Y PPAR Res. 2020; 2020:6287468.

PMID: 32395124 PMC: 7199583. DOI: 10.1155/2020/6287468.

Dietary docosahexaenoic acid decreased lipid accumulation via inducing adipocytes apoptosis of grass carp, Ctenopharygodon idella.

Jin A, Lei C, Tian J, Sun J, Ji H Fish Physiol Biochem. 2017; 44(1):197-207.

PMID: 28918543 DOI: 10.1007/s10695-017-0424-6.

References

Kim E, Park K, Chung S, Sheen Y, Moon D, Song Y . Peroxisome proliferator-activated receptor-gamma activator 15-deoxy-Delta12,14-prostaglandin J2 inhibits neuroblastoma cell growth through induction of apoptosis: association with extracellular signal-regulated kinase signal pathway. J Pharmacol Exp Ther. 2003; 307(2):505-17. DOI: 10.1124/jpet.103.053876. View

Dubey R, Zhang H, Reddy S, Boegehold M, Kotchen T . Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Am J Physiol. 1993; 265(4 Pt 2):R726-32. DOI: 10.1152/ajpregu.1993.265.4.R726. View

Yoo J, Ghiassi M, Jirmanova L, Balliet A, Hoffman B, Fornace Jr A . Transforming growth factor-beta-induced apoptosis is mediated by Smad-dependent expression of GADD45b through p38 activation. J Biol Chem. 2003; 278(44):43001-7. DOI: 10.1074/jbc.M307869200. View

Law R, Meehan W, Xi X, Graf K, Wuthrich D, Coats W . Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest. 1996; 98(8):1897-905. PMC: 507630. DOI: 10.1172/JCI118991. View

Tashiro K, Kawabata K, Sakurai H, Kurachi S, Sakurai F, Yamanishi K . Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J Gene Med. 2008; 10(5):498-507. DOI: 10.1002/jgm.1171. View

Takagi T, Okura H, Kobayashi Y, Kataoka T, Taguchi H, Toda I . A prospective, multicenter, randomized trial to assess efficacy of pioglitazone on in-stent neointimal suppression in type 2 diabetes: POPPS (Prevention of In-Stent Neointimal Proliferation by Pioglitazone Study). JACC Cardiovasc Interv. 2009; 2(6):524-31. DOI: 10.1016/j.jcin.2009.04.007. View

Takeda K, Ichiki T, Tokunou T, Iino N, Takeshita A . 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells. J Biol Chem. 2001; 276(52):48950-5. DOI: 10.1074/jbc.M108722200. View

Kitada K, Ohkita M, Matsumura Y . Pathological Importance of the Endothelin-1/ET(B) Receptor System on Vascular Diseases. Cardiol Res Pract. 2012; 2012:731970. PMC: 3413984. DOI: 10.1155/2012/731970. View

Xiao Y, Yuan T, Yao W, Liao K . 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway. FEBS J. 2010; 277(3):687-96. DOI: 10.1111/j.1742-4658.2009.07514.x. View

10.

Jeon E, Choi H, Lee K, Chang K, Kang Y . Hemin inhibits hypertensive rat vascular smooth muscle cell proliferation through regulation of cyclin D and p21. Arch Pharm Res. 2009; 32(3):375-82. DOI: 10.1007/s12272-009-1310-2. View

11.

Akimoto T, Kusano E, Inaba T, Iimura O, Takahashi H, Ikeda H . Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway. Kidney Int. 2000; 58(1):269-82. DOI: 10.1046/j.1523-1755.2000.00162.x. View

12.

Brisset A, Hao H, Camenzind E, Bacchetta M, Geinoz A, Sanchez J . Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro. Circ Res. 2007; 100(7):1055-62. DOI: 10.1161/01.RES.0000262654.84810.6c. View

13.

Strakova N, Ehrmann J, Dzubak P, Bouchal J, Kolar Z . The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines. J Pharmacol Exp Ther. 2004; 309(3):1239-47. DOI: 10.1124/jpet.103.063438. View

14.

Yuan X, Zhang Z, Gong K, Zhao P, Qin J, Liu N . Inhibition of reactive oxygen species/extracellular signal-regulated kinases pathway by pioglitazone attenuates advanced glycation end products-induced proliferation of vascular smooth muscle cells in rats. Biol Pharm Bull. 2011; 34(5):618-23. DOI: 10.1248/bpb.34.618. View

15.

Wakino S, Kintscher U, Kim S, Yin F, Hsueh W, Law R . Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells. J Biol Chem. 2000; 275(29):22435-41. DOI: 10.1074/jbc.M910452199. View

16.

Ruiz E, Redondo S, Gordillo-Moscoso A, Tejerina T . Pioglitazone induces apoptosis in human vascular smooth muscle cells from diabetic patients involving the transforming growth factor-beta/activin receptor-like kinase-4/5/7/Smad2 signaling pathway. J Pharmacol Exp Ther. 2007; 321(2):431-8. DOI: 10.1124/jpet.106.114934. View

17.

Goetze S, Kim S, Xi X, Graf K, Yang D, Fleck E . Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. J Cardiovasc Pharmacol. 2000; 35(5):749-57. DOI: 10.1097/00005344-200005000-00011. View

18.

Willson T, Lambert M, Kliewer S . Peroxisome proliferator-activated receptor gamma and metabolic disease. Annu Rev Biochem. 2001; 70:341-67. DOI: 10.1146/annurev.biochem.70.1.341. View

19.

Bruedigam C, Eijken M, Koedam M, Chiba H, van Leeuwen J . Opposing actions of rosiglitazone and resveratrol on mineralization in human vascular smooth muscle cells. J Mol Cell Cardiol. 2011; 51(5):862-71. DOI: 10.1016/j.yjmcc.2011.07.020. View

20.

Dannoura A, Giraldo A, Pereira I, Gibbins J, Dash P, Bicknell K . Ibuprofen inhibits migration and proliferation of human coronary artery smooth muscle cells by inducing a differentiated phenotype: role of peroxisome proliferator-activated receptor γ. J Pharm Pharmacol. 2014; 66(6):779-92. DOI: 10.1111/jphp.12203. View